List of insiders holdings for COLLEGIUM PHARMACEUTICAL INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Skyline Venture Partners V LP Skyline Venture Management V LLC 10% Owner |
2017-12-07 19:03:10 | 2,949,916 0 |
2,949,916 | Form 4 |
| 2 | TPG Group Holdings (SBS) Advisors Inc. BONDERMAN DAVID COULTER JAMES G Former 10% Owner |
2017-02-13 15:13:01 | 1,389,863 0 |
1,389,863 | Form 13G |
| 3 | Frazier Healthcare VI L.P. FHM VI L.P. FHM VI L.L.C. FRAZIER ALAN D Naini Nader J Topper James N Every Nathan R 10% Owner |
2020-01-24 13:38:25 | 1,132,399 0 |
1,132,399 | Form 13D |
| 4 | KANEKO YASUNORI 10% Owner |
2017-12-07 19:05:08 | 0 800,540 |
800,540 | Form 4 |
| 5 | Ciaffoni Joseph President and CEO |
2024-02-14 16:13:23 | 444,867 0 |
444,867 | Form 4 |
| 6 | Karnani Vikram President and CEO |
2024-11-14 16:50:17 | 236,316 0 |
236,316 | Form 4 |
| 7 | Brannelly Paul Executive Vice President & CFO |
2021-02-12 16:14:28 | 215,428 0 |
215,428 | Form 4 |
| 8 | Longitude Capital Partners LLC Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Capital Associates L.P. Longitude Venture Partners L.P. 10% Owner |
2019-02-12 17:12:32 | 158,043 0 |
158,043 | Form 13G |
| 9 | Tupper Colleen EVP & Chief Financial Officer |
2025-03-24 17:06:10 | 156,667 0 |
156,667 | Form 4 |
| 10 | Fleming Alison B EVP & Chief Technical Officer |
2021-08-12 16:03:18 | 143,694 0 |
143,694 | Form 4 |
| 11 | Malamut Richard EVP and Chief Medical Officer |
2022-02-14 18:49:23 | 130,264 0 |
130,264 | Form 4 |
| 12 | Kuhlmann Shirley R. EVP and General Counsel |
2025-03-06 18:48:35 | 108,137 0 |
108,137 | Form 4 |
| 13 | Dreyer Scott EVP & Chief Commercial Officer |
2025-03-24 17:05:13 | 103,613 0 |
103,613 | Form 4 |
| 14 | Freund John Gordon Director |
2024-05-16 19:22:42 | 52,468 43,413 |
95,881 | Form 4 |
| 15 | Carlson Douglas R VP Corp. Devlp |
2015-05-06 16:16:52 | 89,720 0 |
89,720 | Form 3 |
| 16 | Smith Thomas B EVP and Chief Medical Officer |
2025-02-12 16:10:38 | 87,742 0 |
87,742 | Form 4 |
| 17 | Kopecky Ernest A see remarks |
2015-05-06 16:18:04 | 80,770 0 |
80,770 | Form 3 |
| 18 | SANTINI GINO Director |
2024-05-16 19:23:49 | 75,656 0 |
75,656 | Form 4 |
| 19 | Dieter David EVP & General Counsel |
2025-03-19 16:36:33 | 68,449 0 |
68,449 | Form 4 |
| 20 | Fallon John A. Director |
2024-05-16 19:22:21 | 54,843 0 |
54,843 | Form 4 |
| 21 | BOHLIN GAREN G Director |
2024-05-16 19:20:35 | 52,468 0 |
52,468 | Form 4 |
| 22 | Melincoff Gwen A Director |
2024-05-16 19:23:27 | 52,468 0 |
52,468 | Form 4 |
| 23 | Heffernan Michael Thomas Director |
2025-02-12 16:10:53 | 50,328 0 |
50,328 | Form 4 |
| 24 | McFarlane Neil F. Director |
2024-05-16 19:23:00 | 49,365 0 |
49,365 | Form 4 |
| 25 | Balice-Gordon Rita J. Director |
2024-05-16 19:22:01 | 46,488 0 |
46,488 | Form 4 |
| 26 | Hirsch David Director |
2020-05-22 16:24:39 | 29,259 0 |
29,259 | Form 4 |
| 27 | Saim Said VP, Pharmaceutical Devlp. |
2015-05-06 16:13:21 | 25,883 0 |
25,883 | Form 3 |
| 28 | Duke Barry S See remarks |
2017-03-21 16:43:20 | 20,087 0 |
20,087 | Form 4 |
| 29 | Schroeder Theodore R Director |
2020-05-22 16:22:11 | 19,102 0 |
19,102 | Form 4 |
| 30 | Heron Patrick J Director 10% Owner |
2015-09-14 16:02:28 | 15,000 0 |
15,000 | Form 4 |
| 31 | Lurker Nancy Director |
2025-02-05 17:30:42 | 12,726 0 |
12,726 | Form 4 |
| 32 | Nadav Eran Director |
2016-06-13 17:47:10 | 8,700 0 |
8,700 | Form 4 |